50 participants
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-18
- Start Date:
- 2024-02-07
- Completion:
- 2028-02-22
Conditions
- Ductal Carcinoma in Situ
Interventions
- BIOLOGICAL
- DRUG
No Results Yet